aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Ramona, United States, BioVentrix, Inc. is a medical device company with a core mission to improve the lives of patients suffering from ischemic cardiomyopathy. The company’s vision is to provide innovative, less invasive treatment options for heart failure. BioVentrix offers the transcatheter ventricular enhancement system, a cutting-edge solution designed to enhance cardiac function and patient outcomes. Their market focus is global, addressing the needs of patients and healthcare providers worldwide.
Notable affiliated individuals include key medical professionals and industry experts who contribute to the company's advancements. BioVentrix has garnered attention from prominent investors in the medical technology sector. The company’s key achievements include successful clinical trials and regulatory approvals that have validated the efficacy of their transcatheter system. Overall, BioVentrix has made a significant impact by offering a novel treatment option that improves the quality of life for heart failure patients globally.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Medical Devices
Technology
Biotech
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Bioventrix founded?
Bioventrix was founded in 2003.
Where is Bioventrix’s headquarters located?
Bioventrix’s headquarters is located in San Ramón, CA, US.
When was Bioventrix’s last funding round?
Bioventrix’s most recent funding round was for $48.5M (USD) in April 2023.
How many employees does Bioventrix have?
Bioventrix has 36 employees as of Feb 5, 2024.
How much has Bioventrix raised to-date?
As of July 05, 2023, Bioventrix has raised a total of $230.2M (USD) since Apr 13, 2023.
Add Comparison
Total Raised to Date
$230.2M
USD
Last Update Apr 13, 2023
Last Deal Details
$48.5M
USD
Apr 13, 2023
Series A
Total Employees Over Time
36
As of Feb 2024
Bioventrix Address
12647 Alcosta Blvd
suite 400
San Ramón,
California
94583-4798
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts